Overexpression of platelet-derived growth factor A-chain (PDGF-A) is clearly linked to autocrine and paracrine stimulation of malignant growth in many human cancers. We have shown previously that PDGF-A overexpression in choriocarcinoma, hepatoma and lung carcinoma cell lines is driven by the activity of a 66 bp enhancer element (ACE66) located approximately 7 kb upstream of the PDGF-A transcription start site. In this study, the ACE66 element is shown to be activated in JEG-3 choriocarcinoma cells through synergistic interactions between consensus DNA motifs for binding of vitamin D receptor, AP1 and ELK1. Binding of the vitamin D/retinoid-X receptor (VDR/RXRa) heterodimer to the ACE66 element was reconstituted in vitro with recombinant VDR/RXRa and with JEG-3 nuclear extract, and was verified in living JEG-3 cells by chromatin immunoprecipitation analysis. Transcriptional activity of the ACE66 element, as well as occupancy of the element by VDR/ RXRa, was shown to be independent of stimulation with the hormonal VDR ligand, 1,25-dihydroxyvitamin D 3 . The jun kinase pathway of mitogen-activated protein kinase (MAPK) signaling was shown to activate the ACE66 enhancer, most likely through activation of factors binding to the AP1 element. These results identify a novel mechanism of transcriptional enhancement involving ligand-independent activity of the VDR/RXR heterodimer and MAPK signaling pathways that appears to play an important role in the overexpression of PDGF in many different settings of human malignancy.
Overexpression of platelet-derived growth factor A-chain (PDGF-A) is clearly linked to autocrine and paracrine stimulation of malignant growth in many human cancers. We have shown previously that PDGF-A overexpression in choriocarcinoma, hepatoma and lung carcinoma cell lines is driven by the activity of a 66 bp enhancer element (ACE66) located approximately 7 kb upstream of the PDGF-A transcription start site. In this study, the ACE66 element is shown to be activated in JEG-3 choriocarcinoma cells through synergistic interactions between consensus DNA motifs for binding of vitamin D receptor, AP1 and ELK1. Binding of the vitamin D/retinoid-X receptor (VDR/RXRa) heterodimer to the ACE66 element was reconstituted in vitro with recombinant VDR/RXRa and with JEG-3 nuclear extract, and was verified in living JEG-3 cells by chromatin immunoprecipitation analysis. Transcriptional activity of the ACE66 element, as well as occupancy of the element by VDR/ RXRa, was shown to be independent of stimulation with the hormonal VDR ligand, 1,25-dihydroxyvitamin D 3 . The jun kinase pathway of mitogen-activated protein kinase (MAPK) signaling was shown to activate the ACE66 enhancer, most likely through activation of factors binding to the AP1 element. These results identify
Introduction
The platelet-derived growth factors (PDGFs) comprise a family of mitogens composed of various dimeric combinations of four polypeptide subunits, PDGF-A, PDGF-B, PDGF-C and PDGF-D (Heldin and Westermark, 1999; Gilbertson et al., 2001; LaRochelle et al., 2001) . The PDGF subunit genes are overexpressed in a wide range of tumor cell lines and tissues, in which they promote malignant growth through autocrine and paracrine pathways (reviewed by Pietras et al., 2003) . While the molecular mechanisms underlying PDGF overexpression in cancer are poorly understood, transcriptional events appear to contribute significantly to the process (reviewed in Kaetzel, 2003) . The promoter and upstream regions of the human PDGF-A chain (PDGF-A) gene contain several positive and negative regulatory elements that regulate basal and inducible transcription. Basal promoter activity has been localized in primate cell lines to the highly GC-rich region between À120 and À40 (Gashler et al., 1992; Lin et al., 1992; Kaetzel Jr et al., 1994) . A number of transcription factors mediate basal transcription upon binding to this region, such as members of the Sp/Kruppel-like factor (KLF) family (Khachigian et al., 1995) , while others such as the Wilms' tumor protein WT1 (Gashler et al., 1992; Wang et al., 1992) , GC factor 2 (GCF2; Khachigian et al., 1999) , nuclear factor I-X (NFI-X; Rafty et al., 2002) and the metastasis suppressor protein NM23 (Ma et al., 2002) are repressive. Specific elements within this region (À102 to À82 and À71 to À55) also appear to mediate transcriptional induction in response to phorbol esters (Bhandari et al., 1995; Khachigian et al., 1995; Silverman et al., 1997) , angiotensin II (Day et al., 1999) , fibroblast growth factor (Silverman et al., 1999) and vascular injury . While these proximal DNA elements and nuclear factors represent plausible candidate mediators for PDGF-A overexpression in transformed cells, their relevance to malignancy remains to be established.
DNA elements in the far upstream region of the PDGF-A gene also contribute to transcriptional control (Maul et al., 1998) . Of particular interest is a 66 bp enhancer element (ACE66) found approximately 7 kb upstream of the transcription start site (À6852 to À6787) that has been shown to be highly activated in many transformed cell lines, including those of choriocarcinoma, hepatoma, osteosarcoma and lung carcinoma origins. The element exhibits minimal activity in all nontransformed cells analysed to date, suggesting its induction may be secondary to oncogenic signaling pathways. Located within the 5 0 -region of the A-chain cell-specific enhancer (ACE) element are two directly repeated AP-1-like motifs separated by a three-nucleotide spacer (AGGTCACTGGGGTCA), a nuclear receptor direct repeat-3 (DR3) sequence commonly associated with binding of vitamin D receptor (VDR) and its heterodimer partner, retinoid-X-receptor (RXR; Mangelsdorf and Evans, 1995) . Additional enhancer activity is contributed by the 3 0 -portion of the element, which contains a binding motif for the c-ETS family member ELK-1. In a recent report (Pedigo et al., 2003) , we have shown the upstream DR3 motif mediates transcriptional induction of the PDGF-A gene by the hormonally active VDR ligand, 1,25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ). In the current study, we show that the activated ACE66 enhancer is occupied in JEG-3 choriocarcinoma cells by the VDR/RXR heterodimer in the absence of vitamin D hormone, and that VDR/RXR binding is required for formation of the fully active enhanceosome. Moreover, we identify a critical role for a third AP-1-like motif that plays an essential integrative role for the 5 0 -and 3 0 -portions of the ACE66 enhancer, and show that it is a sensor for constitutive signaling via the jun kinase component of mitogen-activated protein kinase (MAPK) signaling. Our observations highlight a novel ligand-independent function of VDR, which participates in the formation an enhanceosome that drives expression of PDGF-A in malignant cells.
Results
Transcriptional synergism between binding sites for VDR, AP1 and ELK1 mediates ACE66 enhancer activity in the absence of the VDR ligand, 1,25-(OH) 2 -D 3
The ACE66 enhancer contains a number of consensus sequences for transcription factor binding. To identify those required for enhancer activity, a panel of reporter plasmids was prepared with mutations directed to individual half-sites and other putative response elements. The ACE66 variants were cloned upstream of a minimal PDGF-A promoter fragment (À261 to þ 8) and their enhancer activities analysed by transient transfection in JEG-3 choriocarcinoma cells, a cell line in which the ACE66 element is especially active (B10-fold enhancement; Figure 1a ). While the ACE66 element exhibits basal and vitamin D-inducible enhancer activities from its far upstream location (Maul et al., 1998; Pedigo et al., 2003) , relocation of the element to a position much closer to the promoter amplifies that activity. This enables the detection of subtle mutational effects difficult to observe in the context of the fulllength promoter (À7400 to þ 8), which exhibits lower enhancer activity (threefold) and is a poor transfection substrate due to its substantial length.
A 2 bp substitution within direct repeat A (dr-A), the 5 0 half-site of a nuclear receptor DR3 motif, resulted in a loss of approximately 50% of total enhancer activity ( Figure 1b) . Introduction of the same mutation within dr-B decreased enhancer activity to an even greater extent (80%). Simultaneous mutations within both dr-A and dr-B inhibited enhancer activity to a lesser extent than the dr-B mutation alone, possibly due to inadvertant reconstitution of an artificial DR3 motif. The inhibitory effects of mutations within the dr-A and dr-B half-sites strongly suggested that an intact DR3 motif was required for binding of a transcription-enhancing factor, possibly VDR/RXR. Expression of VDR mRNA and protein expression in JEG-3 cells has been verified by RT-polymerase chain reaction (PCR) (data not shown) and immunoblot analyses, consistent with previous studies of this cell line (Sun et al., 1998; Pedigo et al., 2003) and placental tissues (Pike et al., 1980; Tanamura et al., 1995) . Disruption of dr-C also resulted in a major loss in activity (80%), indicating a central role for this motif and suggesting that a member(s) of the AP1 family may contribute a critical activating function. A 2 bp substitution selectively disrupting the GGA core of an ETS-binding motif (GG-TT) but leaving intact the overlapping dr-C/AP1 site had no significant effect on enhancer activity, indicating the dr-C/AP-1 element is the active component in this region of the element. A mutation within dr-D was without effect (data not shown). Disruption of a consensus binding site for the ETS family member ELK1 at the 3 0 -terminal portion of the ACE66 significantly reduced overall ACE activity by >60%, indicating additional contributions by ELK1 or related transcription factors.
VDR/RXR heterodimers exhibit a strong selectivity for the DR3 arrangement of half-sites, with alterations in the 3 bp spacing shown previously to inhibit protein binding and transcriptional activity (Umesono et al., 1991) . As predicted, a 5 bp insertion (B1/2 helical turn) between half-sites dr-A and dr-B resulted in significantly reduced ACE activity (Figure 1b) . Interestingly, a small, but significant increase in ACE activity resulted from the insertion of 5 bp between dr-B and dr-C. Placement of such an insertion between dr-D and the ELK1-binding motif was without effect (data not shown), indicating a lack of a strict spacing requirement between upstream half-sites A-D and ELK1 motif. Taken together, these results further demonstrate a cooperative interaction between dr-A and the remaining half-sites dr-B and dr-C, and suggested participation of VDR and AP1 in assembly of the transcriptionally active ACE66 enhanceosome. The VDR, AP1 and ELK1 elements were also critical for ACE66 activity in HepG2 hepatoma cells, another setting of enhancer activation (data not shown).
Activation of the ACE66 element in the absence of exogenously added 1,25-(OH) 2 D 3 suggested that the receptor might be constitutively active, possibly through post-translational modification (e.g. phosphorylation) or even endogenous synthesis of the hormone. However, a simple vitamin D response element from the human osteocalcin gene OC-VDRE (Kerner et al., 1989) , which consists of a DR3 motif and only seven flanking , corresponding to À6852 to À6787 in the PDGF-A gene. Dinucleotide substitutions (CC to gg) were introduced into each of the direct repeats A-C, and into the GGA core element of the c-ETS and ELK1-binding sites (GG to tt). Spacing between the dr-A and dr-B half-sites, and between dr-B and dr-C, was increased by insertion of a 5 bp sequence (TCGTA), enclosed in boxes and locations identified with vertical arrows. Oligodeoxyribonucleotides were inserted upstream of an enhancer-less promoter fragment from the PDGF-A gene (À261 to þ 8, AChP) and the luciferase reporter gene. (b) Transient transfection analysis in JEG-3 cells with plasmids containing wild-type and mutant versions of the ACE66 element. DNA motifs disrupted by mutagenesis are identified at the left of the panel using an X. Cells were deprived of exogenous vitamin D metabolites by a 24 h pretreatment with culture medium supplemented with charcoal-stripped fetal bovine serum (FBS). Values shown are corrected for variance in transfection efficiency with a cotransfected b-galactosidase vector, and are normalized relative to activity obtained with the enhancer-less AChP construct. Means with asterisks are significantly different (Pp0.05) from wild-type ACE66, as determined by ANOVA and post hoc t-test nucleotides, exhibited neither ligand-independent nor ligand-dependent enhancer activity in the absence of enforced VDR expression (Table 1) . Interestingly, the OC-VDRE was exquisitely responsive to 1,25-(OH) 2 D 3 when VDR was overexpressed (230-fold induction), indicating that this element is a highly sensitive sensor for any potential activation via endogenous ligand. The strength of vitamin D inducibility suggests cooperativity between the OC-VDRE and the PDGF-A minimal promoter, as the OC-VDRE is induced only 2-3-fold when fused to the HSV thymidine kinase promoter (data not shown). VDR overexpression failed to activate either the OC-VDRE or to superactivate the 5 0 -portion of the ACE element (residues 1-43; ACE1-43), which alone mediates fourfold enhancement (Table 1) . Similarly, VDR overexpression does not augment activity of the full-length ACE66 element (data not shown). These results suggest that if VDR is part of the activated ACE66 complex, its intracellular concentrations are not limiting in JEG-3 cells. Taken together, ACE activity in JEG-3 cells requires the cooperative interaction of direct repeats A-C and the 3 0 ELK-1 site, and that a VDRbinding site alone is insufficient for enhancer activation.
MAPK signaling regulates ACE enhancer activity
The AP1 and ELK1 motifs located within the ACE66 element represent potential targets of signaling from MAPK pathways. A likely candidate for transcriptional activation through such motifs is the stress-activated MAPK pathway, which leads to the activation of MAPKs in the c-Jun N-terminal kinase (JNK/SAPK) subfamily and, ultimately, increases transactivating activity of the transcription factors c-JUN, ELK1 and ATF2. Enforced expression of a constitutively active form of MEKK1 (DMEKK1; Guan et al., 1998) , the most upstream kinase of the JNK/SAPK cascade, elicited a significant increase in enhancer activity of the full-length ACE66 element ( Figure 2a ). Overexpression of c-JUN also appeared to stimulate ACE66 activity, although the effect did not quite reach statistical significance (Po0.1). No effects of DMEKK1 or c-JUN expression were obtained with the PDGF-A promoter fragment alone, verifying that the induction was directed to the enhancer. To further localize subregions of the ACE66 element specifically targeted by the JNK/SAPK cascade, effects of DMEKK1 and c-JUN overexpression on 5 0 -and 3 0 -terminal subfragments of the enhancer were assessed. The 5 0 -terminal subfragment consisted of residues 1-43 (ACE1-43) and contained the VDR and central AP1 (dr-C)-binding motifs. The 3 0 -terminal subfragment was derived from residues 23-66 (ACE23-66) and also contained the AP1 site, plus the ELK-1 element. Overexpression of both DMEKK1 and c-JUN increased enhancer activity from each of the ACE1-43 and ACE23-66 subfragments by approximately twofold. The central AP1 motif would appear to be a primary target of the JNK/SAPK cascade since both of these ACE66 subfragments share the AP1 site. Moreover, the JNK/SAPK cascade is well known for its ability to activate factors that interact with classical AP1 elements (Karin, 1998) . However, transcription factors binding to the VDR and ELK-1 sites cannot be excluded as targets of the cascade at present.
To address more directly whether the JNK/SAPK cascade contributes to the elevated ACE66 activity in JEG-3 cells, we measured the ability of dominantnegative c-JUN and c-FOS proteins to inhibit the enhancer. For these studies, a plasmid construct containing three tandem copies of the ACE66 element (3X ACE) was employed. The dominant-negative c-JUN construct used was GFP-TAM67, which lacks the transactivation domain between amino-acid residues 3-122 (Brown et al., 1993) , and is fused to green fluorescence protein as described (Hennigan and Stambrook, 2001 ). The dominant-negative c-FOS protein, A-FOS, contains a substitution of the basic DNAbinding domain with an acidic amphipathic peptide (Olive et al., 1997) , thereby interfering with normal binding of AP1 complexes to DNA. The three tandem copies of the ACE66 element resulted in a greater than 200-fold enhancement (Figure 2b ), a transcriptional synergism described previously (Maul et al., 1998) . As expected, DMEKK1 and c-JUN superinduced the 3X ACE construct by approximately twofold. Expression of GFP-TAM67 resulted in an approximately 70% reduction in enhancer activity, while A-FOS expression was also inhibitory, albeit to a lesser extent. Activity of the minimal PDGF-A promoter was unaffected by expression of any of the recombinant proteins. By virtue of the ability of TAM67 to block actions of AP1 in a dominant-negative fashion by binding to its DNA motifs without activating transcription, we conclude that the AP1 element is required for full ACE66 activity and that transcription factors of the AP1 family are likely to mediate this activation. This conclusion is bolstered by the inhibitory activity of A-FOS, which exerts its effect by dimerizing with, and thereby inactivating, proteins of the JUN and ATF families. Modest inhibition (20%) of enhancer activity for the full-length ACE66 and ACE modules 1 and 2 was seen at low concentrations with pharmacological inhibitors of the jun-K (SP600125) and p38 MAPKs (SB202190), but not the ERK pathway (PD98059), suggesting both jun-K and p38 may provide activating signals to transcription factors at the AP1 element (data not shown).
Complexes formed between the ACE66 element and nuclear proteins from JEG-3 cells contain both VDR and RXRa
In an earlier study, ethylation interference footprinting analysis of nuclear extracts from JEG-3 choriocarcinoma P on either the coding (left) or noncoding (right) strand. These were incubated with the indicated amounts of baculoviral extract protein (1.5-15 mg) containing recombinant human VDR/RXRa heterodimer or nuclear extract protein (10 mg) from JEG-3 and Saos-2 cells, then treated with DNase I, and cleavage products resolved on 6% sequencing gels. Boundaries of relevant direct repeats and other motifs are represented at the left of each panel, while boundaries of footprints (FP) and DNase-hypersensitive regions (HS) are represented at the right of each gel with brackets. (b) Ethylation interference footprinting was conducted with the same probes used in (a), as described in Materials and methods. Ethylated probes (0.3 pmol) were incubated with recombinant VDR/RXR (150 mg baculovirus extract protein) or JEG-3 nuclear extract (800 mg), subjected to nondenaturing electrophoresis to isolate MR3 complex-associated bound (or B) and free (F) DNA, and cleaved with either piperidine at guanine (G) or sodium hydroxide at phosphate (PO 4 ) residues. Key nucleotide residues are identified as footprints (FP) by virtue of their under-representation in the bound versus free lanes in the gel patterns shown cells revealed strong protein contacts over the DR3 motif of the ACE element. To verify whether the DR3 motif was indeed recognized as a VDR/RXR-binding site, DNAse I footprinting was conducted with recombinant human VDR/RXRa and a 32 P-end-labeled 96-mer that contained the ACE element and flanking nucleotides. The analysis revealed distinct contacts between VDR/RXRa and the DR3 motif on both coding and noncoding DNA strands of the ACE (Figure 3a, lanes 1-4 and 13-16) . A pronounced DNase I-hypersensitive site was induced just downstream of the motif by VDR/RXRa occupancy, probably from the projection of torsional stress through the DNA helix. The footprint obtained on the coding strand with JEG-3 nuclear extract (lanes 5-8) was essentially identical in its dimensions, albeit less robust, to that obtained with the comparatively large quantities of recombinant VDR/ RXRa employed. On the noncoding strand, proteinnucleotide contacts were apparent not only over the DR3 motif but also extended to the AP1 motif and beyond (lanes 17-20). DNase I footprinting was also conducted with nuclear extract from Saos-2 cells, which exhibit no PDGF-A gene transcription nor ACE66 activity (Maul et al., 1998) , but do express significant quantities of VDR (Mulkins et al., 1983) . Interestingly, the dimensions and intensity of footprints obtained with the Saos-2 nuclear extract were similar on both strands of the ACE66 element to those obtained with JEG-3 extract (Figure 3a and b, lanes 9-12 and 21-24). This result indicates that occupancy of the DR3 motif is constitutive and independent of enhancer status. In turn, these data suggest that simple occupancy of the element is insufficient for enhancer activation.
Ethylation interference footprinting (EIF) was also employed to provide complementary insights into the features of DNA binding between the VDR/RXR heterodimer and nuclear proteins from JEG-3 cells. While DNase I protection footprinting elucidates the topography of protein-DNA binding (i.e. nucleotides obscured from nuclease action), EIF identifies specific nucleotide residues required for high-affinity protein binding. In addition, EIF permits the mapping of protein contacts with both guanine and phosphate residues in DNA in a single experiment, through the parallel application of cleavage chemistry with piperidine or sodium hydroxide (Bu¨ning et al., 1995) . Using the EIF approach, strong contacts between recombinant VDR/RXRa and both guanine (Figure 3b ; compare lanes 1 and 2, 9 and 10) and phosphate residues (compare lanes 3 and 4, 11 and 12) were observed within the VDRE region of the ACE66 element. The limits of the VDR/RXRa-induced footprints were in close agreement with those obtained by DNase I footprinting (Figure 3a) . Moreover, JEG-3 nuclear extract elicited strong footprinting patterns over guanine (compare lanes 5 and 6, lanes 13 and 14) and phosphate (compare lanes 7 and 8, lanes 15 and 16) residues in the dr-A and dr-B motifs, consistent with previous results (Maul et al., 1998) . Footprinting was observed over essentially all phosphate residues of the DR3 site on the coding strand, including both the half-sites and the 3 bp spacer sequence, while interference on the noncoding strand was seen at the dr-A and dr-B motifs but not within the spacer nucleotides. The similarities in footprinting patterns elicited by JEG-3 nuclear extract to those obtained with recombinant VDR/RXRa suggested that the DR3 motif is indeed occupied by endogenous VDR/RXRa.
The importance of the DR3 motif in formation of complexes between the ACE element and JEG-3 nuclear proteins was addressed directly by assessing the impact of mutations within half-sites dr-A and dr-B in electrophoretic mobility shift assays (EMSAs). Incubation of a radiolabeled ACE1-43 with JEG-3 nuclear extract yielded a complex of 3-4 bands (Figure 4a , lane 1), termed the MR3 complex in previous studies (Maul et al., 1998) . The complex was efficiently competed away with increasing concentrations of homologous, unlabeled ACE1-43 oligonucleotide (lanes 2-5), while disruption of either dr-A (lanes 6-9) or dr-B (lanes 10-13) resulted in significantly reduced competing activity. Further analysis of these data as competitive binding isotherms revealed an 8-10-fold loss in the affinity of MR3 proteins for either the dr-A or dr-B mutant oligodeoxyribonucleotides (Figure 4b) . We have previously shown that mutations within dr-A or dr-B greatly diminish their ability to compete with a radiolabeled subfragment of the ACE element (nucleotides 1-43, or ACE1-43) for binding to recombinant VDR/RXRa (Pedigo et al., 2003) . Taken together, these data reinforce the importance dr-A and dr-B in the formation of the MR3 complex and are consistent with occupancy of the DR3 motif by VDR/RXR, or related nuclear receptor heterodimers.
To determine more directly whether MR3 complex bands formed between JEG-3 nuclear proteins and the ACE element contained VDR and RXR, their reactivities with anti-VDR and anti-RXR antibodies were analysed in vitro by EMSA. Antiserum directed to the hinge region of VDR efficiently blocked formation of most of the MR3 bands except for trace amounts of a minor species (Figure 5a ). Antibodies directed to the DNA-binding and hinge domains of VDR often inhibit, rather than supershift DNA-VDR complexes (Smith et al., 1991; Liu et al., 1996; Hakim and Bar-Shavit, 2003) . The demonstration of VDR in almost all of the MR3 bands excludes significant occupancy of the site by RXR/RXR homodimers. Antibody specific for RXRa supershifted MR3 complexes to a high degree, indicating the presence of RXRa in a significant proportion of the MR3 bands. Anti-RXRb and anti-RXRg were ineffective (data not shown), suggesting RXRb and RXRg are absent from these binding complexes. Binding of VDR and other nuclear receptors to direct repeat sequences such as the DR3 motif sequences requires a dimeric protein structure, with each receptor monomer binding to a corresponding single direct repeat element (Mangelsdorf and Evans, 1995) . Thus, the results of this analysis indicate that the majority of MR3 bands are VDR-containing dimers, and that a significant proportion of the MR3 complexes represent VDR/RXRa heterodimers. MR3 bands failing to supershift with anti-RXRa antibody are likely to be VDR/RXRa heterodimers that eluded incorporation into immune complexes, although the presence of VDR homodimers cannot be formally excluded for these bands.
To verify that the ACE66 element was occupied by VDR in living JEG-3 cells, chromatin immunoprecipitation (ChIP) analysis was conducted. Significant amounts of ACE66-containing chromatin fragments were immunoprecipitated using an antiserum reactive with the C-terminal region of human VDR (Koszewski et al., 1998) , and detected by PCR with primers spanning the element (Figure 5b, left) . This antiserum also detected occupancy of the ACE66 element by VDR in JEG-3 cells treated with 1,25-(OH) 2 D 3 (right). Although the band intensity shown for chromatin from 1,25-(OH) 2 D 3 -treated cells was slightly higher than that from control cells, the difference was not consistently seen over the course of repeated assays. Anti-RXRa antibody also precipitated significant levels of DNA containing the ACE element from vitamin D-depleted JEG-3 cells (Figure 5b EMSA and antibody incubations were performed as described under 'Materials and methods'. JEG-3 cell nuclear extract (10 mg protein) was coincubated with 32 P-radiolabeled ACE1-43 probe and with the anti-VDR or RXR antibodies indicated above each lane. preI serum, preimmune rabbit serum; anti-VDR, rabbit antiserum directed to the hinge region of VDR; preI IgG, purified IgG fraction from preimmune serum; anti-RXRa, purified IgG fraction of rabbit antisera directed to the RXRa isoform (Santa Cruz). MR3 complexes are identified with a bracket at the left of both gels, and supershifted complexes (SS) are identified with arrows at right. (b) Chromatin immunoprecipitation assay (ChIP) demonstrates occupancy of the ACE element by VDR, RXRa and acetylated histone H4 in living JEG-3 cells. ChIP assays were conducted as outlined in 'Materials and methods'. Chromatin was isolated from cells in the absence of (À1,25 D 3 , top and bottom left) and after 4 h treatment with 10 À7 M 1,25-(OH) 2 D 3 ( þ 1,25 D 3 , top right). Immunoprecipitation was conducted with the antibodies indicated in the figure, as follows: anti-VDR, rabbit anti-Cterminal VDR serum 195 (Koszewski et al., 1998) ; anti-H4, antiacetylated histone H4 (Upstate); anti-RXRa, same as in (a)
Discussion
The current study has uncovered multiple aspects of the mechanism responsible for hyperactivity of the ACE66 enhancer in choriocarcinoma and possibly other cancer cell types. Enhancer function was shown to require cooperative interactions between binding motifs for the transcription factors VDR, AP1 and ELK1, as well as activation via the junK pathway of MAPK signaling, which are outlined in the model shown in Figure 6 . The high degree of cooperativity between multiple DNA elements and intracellular signaling pathways is consistent with the concept of the enhanceosome, multimodular complexes that provide high synergy and specificity of transcriptional activation (Thanos and Maniatis, 1995; Merika and Thanos, 2001) . Of particular interest was the novel contribution of VDR to activation of the ACE66 enhanceosome, which was achieved in the absence of its cognate ligand, 1,25-(OH) 2 D 3 . Ligand-independent activity of the VDR has been described previously in the context of the prolactin promoter, in which a similar enhanceosome and activating mechanism involving the transcriptional cofactors GHF-1 and c-ETS was identified (Tolon et al., 2000) .
Evidence for ligand-independent activation of VDR was obtained through a number of complementary approaches. Mutational analysis of the putative VDRbinding site, a classical nuclear receptor DR3 motif, demonstrated that both half-sites and correct 3 bp spacing between them were required for full enhancer function. The DR3 motif was also necessary for high affinity binding of recombinant VDR/RXRa heterodimers, as well as for the formation of complexes between the ACE element and nuclear proteins from JEG-3 choriocarcinoma cells in vitro. Complexes formed in vitro between the ACE66 element and JEG-3 nuclear extracts were shown to contain VDR and RXRa by their reactivity with specific antisera, while occupancy of the ACE66 element by these proteins was verified in living JEG-3 cells by ChIP assay. However, while binding of VDR/RXRa to the DR3 motif appears to be necessary for optimal ACE66 activation, it is not sufficient. DNase I footprinting demonstrated occupancy of the DR3 motif in Saos-2 cells, which express high levels of VDR but exhibit no ACE66 enhancer activity or detectable PDGF-A expression. In addition, our previous studies have shown that an ACE subfragment consisting of its 5 0 -most 33 nucleotides, which contains only the DR3 and AP1 motifs, possesses negligible enhancer activity (Maul et al., 1998) . Similarly, a vitamin D response element (VDRE) from the osteocalcin gene alone lacked enhancer activity in JEG-3 cells (Table 1) .
A number of lines of evidence indicate that the contribution of VDR to the transcriptionally active ACE66 enhanceosome in JEG-3 cells does not require activation by its cognate ligand, 1,25-(OH) 2 D 3 . The DR3 motifs of the ACE66 and OC-VDRE fail to mediate constitutive enhancer activity on their own in this cell line, even though both are highly inducible with exogenous 1,25-(OH) 2 D 3 . This is particularly true for the OC-VDRE, which is remarkably sensitive to 1,25-(OH) 2 D 3 treatment when fused to the minimal PDGF-A promoter (>200-fold induction). The presence of endogenous 1,25-(OH) 2 D 3 in this cell system would have resulted in pronounced transcriptional induction with the OC-VDRE/PDGF-A promoter combination. In addition, the potential supply of exogenous vitamin D precursors or metabolites in the culture medium was minimized by use of charcoal-stripped fetal calf serum. It is widely accepted that cells capable of 1a-hydroxylation must be furnished with precursors (e.g. 25-(OH)D 3 ) or vitamin D metabolites synthesized elsewhere (Brown et al., 1999) , with de novo synthesis of the hormone yet to be observed in any single cell type. Finally, the ACE element remains fully active in JEG-3 cells after 7 days of culture in serum-free medium (data not shown), a period almost certain to deplete any residual exogenous vitamin D compounds or hormone precursors. Figure 6 Model depicting bound transcription factors and MAPK signaling to the ACE66 element in the absence of vitamin D. It should be noted that occupancy of the respective AP1 and ELK1 motifs specifically by JUN-FOS and ELK1 dimers is hypothetical, as other members of these transcription factor families are equally plausible candidates. Also hypothetical is the displayed recruitment of the DRIP complex to the unliganded VDR/RXR heterodimer; coactivators that associate with VDR/RXR and mediate transcriptional activity of the ACE element are yet to be identified The ACE element is unusually distant from the PDGF-A transcription start site (B7 kb), suggesting novel interactions of VDR with the transcriptional apparatus. Of particular interest is the possibility that VDR may play an important role in eliciting broad alterations in chromatin structure for the PDGF-A gene, an activity which could be manifested at such a long distance from the transcription start site. Many members of the nuclear receptor superfamily can promote chromatin decondensation and transcriptional derepression through the recruitment of factors that have intrinsic histone acetylase activity (for reviews, see Lemon and Freedman, 1999; Xu et al., 1999) . Studies are ongoing to determine whether coactivator complexes recruited to the ACE element in choriocarcinoma cells by VDR are qualitatively different from those recruited by ligand-activated VDR, the latter of which would be predicted to correspond to the DRIP (vitamin D 3 receptor interacting protein, see Figure 6 ) complex initially described by Freedman and co-workers (Rachez et al., 1999) .
The centrally located AP1 motif (dr-C) plays an essential role in the overall function of the ACE66 enhancer, with disruption of the site causing an 80% reduction in overall enhancer activity (Figure 1b) . While the DR3 motif alone is transcriptionally inactive, a 5 0 -terminal ACE subfragment that adds the AP1 site and 10 additional bp of 3 0 -flanking DNA (nucleotides 1-43, or 'module 1'; Kaetzel, 2003) exhibits significant enhancer activity (Maul et al., 1998) . Similarly, the AP1 site confers enhancer activity to the otherwise inactive 3 0 -terminal ELK1 site (nucleotides 33-66, or 'module 2'). The abilities of MEKK1 and c-JUN to superinduce enhancer activities of both modules 1 and 2 strongly suggest that constitutive activation of the jun-K pathway, a known activator of AP1 complexes, provides a critical stimulus to the ACE66 enhanceosome via the AP1 element. The inhibitory action of TAM67, a dominant-negative mutant form of c-JUN that is DNA binding-competent but lacks transactivating activity, provides further confirmation. While the protein(s) that binds to the AP1 element and represents the end point of this pathway remain to be identified, one or more members of the JUN and ATF transcription factor families represent logical candidates. This notion is reinforced by our observation that forced expression of A-FOS, a DNA-binding-defective mutant that forms inactive AP1 complexes upon dimerization with JUN and ATF proteins, reduces ACE enhancer activity. Conclusive identification of the factors that bind to the AP1 and ELK1 element, however, is likely to require labor-intensive approaches of direct enhanceosome purification, or ChIP analysis with large panels of antisera directed to AP1 and c-ETS family members.
While the highly ordered structure of the ACE66 element suggests a role in physiological regulation of the PDGF-A gene, such a function remains unclear at present. In spite of its responsiveness to modulation of MAPK signaling in the current study, the ACE66 element is not induced by a wide range of growth factors (PDGF, EGF/TGFa, FGF, TGFb, serum) known to activate MAPK cascades and PDGF-A gene transcription (data not shown). This suggests that the ACE66 enhanceosome may only respond to a combinatorial and specific code of transcription factors and activating signals, invoked in a limited number of physiological settings. To identify conditions in which the ACE66 element is activated in vivo, transgenic mice harboring transcriptional cassettes consisting of the element in fusion with the PDGF-A promoter and the GFP reporter gene have been created. However, the element is inactive in all tissues and ages (pre-and postnatal) examined (Ma et al., manuscript in preparation) . This observation is not surprising when taken in the context of the recently reported mouse genome sequence, which has revealed a complete absence of direct repeat motifs in the ACE element. Thus, the only compelling function proposed to date for the element remains its apparent role in driving PDGF-A overexpression in human cancer.
The ligand-independent activity of the VDR observed in the context of the PDGF-A gene is reminiscent of the aberrant activation of estrogen and androgen receptors via MAPK signaling in carcinomas of the breast and prostate (Hart and Davie, 2002; Taplin and Balk, 2004) . Ligand-independent activation of these steroid receptors is linked with hormone-independent growth, a hallmark of advanced malignancy and poor responsiveness to hormonal and conventional antineoplastic therapies. Our studies suggest that VDR represents a novel nuclear receptor target for MAPK-induced, ligand-independent activation in human cancer. Moreover, its role in the overexpression of PDGF, a long-recognized inducer of cellular transformation and angiogenesis, provides a plausible molecular mechanism through which ligandindependent activity of VDR may induce malignant growth. We have already identified at least five tumor cell types (choriocarcinoma, hepatoma, osteosarcoma, carcinomas of lung and cervix) in which the ACE66 element is activated, perhaps reflecting the ubiquitous expression of VDR in human cells. Thus, the molecular mechanism associated with activation of the ACE66 element may provide potentially valuable prognostic markers and therapeutic targets across many types of cancer.
Materials and methods

Plasmid constructs and oligodeoxynucleotide synthesis
Construction of the luciferase reporter construct pAC261-luc (identified as pAChP in the current study) and derivatives containing full-length and truncated forms of the ACE66 enhancer have been described (Maul et al., 1998) . For the mutational analysis of enhancer and protein binding activities of the ACE element, a panel of double-stranded oligonucleotides were synthesized (Integrated DNA Technologies) that contained the ACE element and various nucleotide substitutions, as described in the text. Complementary strands were annealed and inserted at the NheI site of pAChP-luc. The plasmid pAChP-OC-VDRE was constructed by insertion of a 29 bp VDRE from the human osteocalcin gene (5 0 -CGCGTCACCGGGTGAA CGGGGGCATTGCG-3 0 ; Kerner et al., 1989) into pAChPluc. All newly constructed plasmids were sequenced to confirm correct insertion of oligodeoxynucleotide sequences. Expression vectors for the MAPK cascade, MEKK1D367 and EEJun, were generous gifts of Dr Dennis Templeton (Department of Pathology, U. of Virginia). MEKK1D367 is a constitutively-active variant of MEKK1, while EE-Jun is an epitopetagged c-JUN (Guan et al., 1998) . TAM67 is a c-JUN-derived dominant negative with the N-terminal transactivation domains deleted (Smeal et al., 1991) . A-FOS has the leucine zipper of c-FOS with an acidic a helix in place of the DNA-binding domain (Olive et al., 1997) . A double-stranded oligodeoxynucleotide containing the ACE sequence plus 30 bp of DNA flanking the 5 0 end of the element (ACE96; 5 0 -AGCGCTCTGGGGTTGGCCTGGGCTTTAACCGGGT GACCCCAGTGACCTGCCGGATGACTCAGGCCCACG CCTGCCCCACCTTGGAACTCGGAATTC-3 0 ) was synthesized for DNA footprinting experiments.
Cell culture and transient transfection JEG-3 cells were obtained from the American Type Culture Collection and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% (v/v) fetal bovine serum (FBS), 10 mM nonessential amino acids, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. JEG-3 cells were plated 24 h prior to transfection at 10 5 per 35 mm dish and were transfected by calcium phosphate-DNA coprecipitation (Graham and Van der Eb, 1973) . Transfections were conducted with 0.7 mg of reporter plasmid, 0.15 mg of a CMV promoter-driven expression plasmid (pL2-VDR) containing a cDNA encoding human VDR and 0.7 mg of the reference plasmid pRSV-bgal to correct for variations in transfection efficiency. At 16 h after transfection, cells were treated for 24 h with DMEM supplemented with charcoal-stripped FBS (Sigma) containing concentrations of 1,25-(OH) 2 D 3 (Leo Pharmaceuticals, Denmark) indicated in the text. Cell lysates were prepared and analysed for luciferase and b-galactosidase activities as described (Maul et al., 1998) . Transfections of JEG-3 cells with ACE reporter and MAPK expression plasmids were carried out using a Lipofectamine protocol. Plates (24 well) were seeded with 3.5 Â 10 4 cells the day before transfection. Each well was transfected with 0.24 mg of reporter plasmid and 0.04 mg of MAPK expression plasmid. Owing to the stimulatory effects of MAPK and c-JUN expression plasmids on viral promoters available for b-galactosidase coexpression (e.g. CMV, RSV, SV40), corresponding luciferase values were expressed instead in terms of activity per micrograms cell lysate protein. This approach for standardization was validated by the lack of effect of MAPK and c-JUN expression on lysate protein-corrected activity obtained with the enhancer-less AChP construct. All transfections were performed with duplicate dishes in three independent or more experiments.
EMSA
EMSAs were conducted as described (Maul et al., 1998) , with nuclear extracts (10 mg per binding reaction) prepared by the method of Dignam et al. (1983) . Recombinant human VDR and human RXRa were generated using the baculovirus expression system as described . The anti-VDR preparation Ab202, which is directed to the hinge region of the receptor, was employed as an ACE complexblocking reagent. Anti-RXR sera directed to the extreme N-termini of the RXR isotypes a, b and g were obtained commercially (Ligand Pharmaceuticals). Antisera (1 ml) were incubated with nuclear extracts or recombinant proteins for 1 h at 41C before addition of radiolabeled DNA. Gels were dried and radioactive bands visualized by phosphorimaging (Storm 840, Molecular Dynamics).
DNase I and ethylation interference footprinting
DNase I footprint analysis was carried out by using the Core Footprinting System (Promega). 32 P-end-labeled ACE96 probe (30 fmol) was incubated with different concentrations of JEG-3 nuclear extracts or recombinant VDR/RXRa, as indicated in the text. Recombinant VDR/RXRa heterodimers were formed by coincubation of the receptor monomers as described (Pedigo et al., 2003) , which were prepared separately using a baculovirus expression system. The DNA-protein-binding reaction was exposed to 0.75 U of RNase-Free DNase I for 1 min at room temperature. The reaction was terminated by addition of stop solution (1% SDS, 0.2 M NaCl, 20 mM EDTA, 0.25 mg/ml yeast tRNA, pH 8.0) and extracted by phenol : chloroform : isoamyl alcohol (25 : 1 : 24). The digested DNA was precipitated by ethanol and loaded on 12% sequencing gels, followed by phosphorimaging. Ethylation interference footprinting was conducted essentially as described (Bu¨ning et al., 1995) , and as modified by our laboratory (Maul et al., 1998) . EMSAbinding reaction mixtures contained 150 mg of baculovirus extract containing VDR/RXRa heterodimer protein or 800 mg of JEG-3 nuclear extract, 800 mg poly(dI-dC) and 0.3 pmol of 32 P-end-labeled, ethylated probe DNA.
ChIP
ChIP assays were performed using a modification of the method of Farnham (1997, 1999 ) and a commercially available kit (ChIP Assay Kit, Upstate). JEG-3 cells were grown to near confluence (1.0-1.5 Â 10 7 cells per 100 mm dish), incubated for 18 h in DMEM supplemented with charcoalstripped FBS, and either treated or not with 1,25-(OH) 2 D 3 for 4 h (10 À7 M). Crosslinking of protein-DNA complexes in vivo was performed by adding 37% formaldehyde solution (SigmaAldrich) to the culture medium (final concentration, 0.4%) followed by incubation with shaking for 10 min at room temperature. Cells were then washed twice in cold PBS (all subsequent steps conducted at 41C), scraped in 1 ml PBS with protease inhibitors (1 mg/ml aprotinin, 1 mg/ml pepstatin A, 1 mg/ml leupeptin, 100 mM PMSF) and centrifuged (2000 r.p.m., 4 min, 41C). Cell pellets were washed once with 1 ml PBS with protease inhibitors, resuspended in 1 ml cell lysis buffer (5 mM PIPES pH 8.0, 85 mM KCl, 0.5% NP-40 and protease inhibitors) and incubated for 10 min. Cells were lysed with 10 strokes in an all-glass Dounce homogenizer (loosefitting pestle). Nuclear pellets were recovered by centrifugation (5000 r.p.m., 5 min), resuspended in nuclei lysis buffer (50 mM Tris-HCl pH 8.1, 1% SDS, 10 mM EDTA and protease inhibitors) for 10 min. Nuclear lysates were sonicated (Sonic Dismembrator, Model 500, Fisher Scientific) in 500 ml aliquots in the presence of 0.1 g acid-washed glass beads (212-300 mm; Sigma-Aldrich). Sonication was performed with four pulses of 15 s, each separated by 1 min on ice at a power setting of 400 W, 20 kHz and 20% amplitude. Chromatin sonicates were centrifuged (14 000 r.p.m., 10 min, 41C) and supernatants stored at À801C. An aliquot of the sonicated chromatin was heated per the Upstate protocol to reverse the crosslinks, and agarose gel electrophoresis was performed to verify shearing of DNA to an average size of 500-700 bp. For immunoprecipitations, 100 ml aliquots of sonicated chromatin (representing 2.0 Â 10 6 cells) were diluted 10-fold in ChIP dilution buffer (16.7 mM Tris-HCl pH 8.1, 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 167 mM NaCl and protease inhibitors) and precleared with 40 ml protein A agarose slurry for 30 min at 41C with agitation. Aliquots of precleared chromatin were incubated with the appropriate antibody overnight at 41C with agitation. The analysis employed three different rabbit polyclonal antibodies, which included a rabbit serum directed to the C-terminus of VDR (Koszewski et al., 1998) , rabbit anti-RXRa (IgG fraction, Santa Cruz) and rabbit anti-histone H4 serum (Upstate). Immune complexes were precipitated with 60 ml protein A agarose slurry for 1 h at 41C with agitation, followed by gentle centrifugation (1000 r.p.m., 1 min, 41C). Protein A agarose pellets were washed, eluted and protein-DNA crosslinks were reversed according to the Upstate protocol. DNA was recovered by column chromatography (Min-Elute, Qiagen Inc., Valencia, CA, USA) according to the manufacturer's protocol. Immunoprecipitated DNA was analysed by standard end point PCR. A 149-bp fragment containing the ACE66 element plus 73 and 10 bp of 5 0 -and 3 0 -flanking nucleotides, respectively, was amplified, resolved by nondenaturing polyacrylamide gel electrophoresis (6% polyacrylamide, 0.5 Â TBE), and detected by staining with Syber Green I (Amersham) and phosphorimaging. Primers used in the PCR reaction are as follows (5 0 -3 0 ): forward primer, ACGGTCACGAGAGGAACAGAGGCT (À6925 to À6902); reverse primer, TGTTGGATGTGAATTCCGAGTT CC (À6777 to À6800).
Abbreviations ACE, A-chain cell-specific enhancer; ChIP, chromatin immunoprecipitation; DMEM, Dulbecco's modified Eagle's medium; DR3, direct repeat-3; EIF, ethylation interference footprinting; EMSA, electrophoretic mobility shift assay; FBS, fetal bovine serum; MAPK, mitogen-activated protein kinase; MR, mobility region; PDGF, platelet-derived growth factor; RXR, retinoid-X receptor; VDR, vitamin D receptor; VDRE, vitamin D response element; 1,25-(OH) 2 D 3 , 1, 25-dihydroxyvitamin D 3 .
